Registrations
Speakers
Future of Personalized Medicine Summit is a 2-day networking online event with revolutionary keynotes, case studies, and panel discussions. It brings together experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics to discuss how AI and Blockchain technologies are impacting the Future of Medicine. A one of a kind forum to benchmark, gain subject matter expertise & business intelligence by collaborating with industry leaders from the field of Engineering, Diagnostics, Bioinformatics, Drug Discovery, Therapies and more.
Cancer is a genetic disease driven by heritable or somatic mutations, new DNA sequencing of cancer genomes will have a significant impact on the detection, management, and treatment of the disease.
Further targeted therapies have become the new standard of care in oncology, and the use of NGS techniques in diagnostics is widely being utilized for the selection of treatments to optimize patient outcomes. From a clinical perspective, NGS presents great potential in the future to optimally manage human healthcare needs.
The discussion around Big Data's Role in Personalized Medicine has been popularized in the healthcare environment. However, its successful implementation has yet to come to fruition as healthcare entities and providers struggle to leverage Big Data for personalized care.
We are dealing with data from internal (individual traits) as well as the external environment, integrating all the data with new technologies will be a challenge, but one that can be successfully dealt with the use of statistical tools, computer scientists, and others.
Personalized medicine as in its nature recognizes treatment based on an individual's condition, rather than a one-size-fits-all prescription. Adding to the mix, digital technology has contributed significantly to understanding the disease and the needs for value-based care, with cost-effective alternatives (like wearables).
This not only promises quality in clinical care but also reducing health care costs. Personalized medicine tests will be created where the development in "omics" sciences (such as genomics) will provide a further boost. Despite this, an improper incentive structure amongst the stakeholders could result in falling back on the PM development.
“ As a result of biomedical advances, we are facing the possibility of a future in which our humanity itself will be altered beyond recognition.” - Francis Fukuyama
Innovative keynotes delivered by the industry's true heavyweights, covering practical challenges and subjects which are exclusively entailed in our agenda. Gain subject matter expertise, network, and collaborate to explore solutions that shed light on future business models impacting revenue inflows.
Futurista Start-up Elevate is a dedicated platform for Startups and VCs. We offer industry-specific startups a showcasing opportunity, enabling them to connect with corresponding VCs and Mentors. A win-win dynamic is created to attain the desired exposure for startups who are looking forward to scaling up their businesses.
A smart application will help you connect with key decision makers, share files, brainstorm ideas, and have a seamless networking experience. A comprehensive module covering the entire event, compiled for training purposes, to be made available post-conference, exclusively for the attendees.
Digital medicine
Personalized health care technology
Mobile health (mHealth)
Digital Health
Wearables Technology
Targeted therapy
Evidence Based Medicine
Precision Oncology
Digital phenotyping
Genome targeted drugs
Computational genomics
Biochips
Digital Biomarker
Nutrigenomics
Value based pricing
Next Gen Sequencing
Microbiomics
DNA Database
CRISPR Cas9
Proteomics
Personalized Medical Devices
Biobanking
Companion Diagnostics
Nanomedicine
Electronic Health Record
Organ on chip
Telemedicine
DNA Profiling
Predictive Medicine
Preventive Medicine
Personalised Cancer Vaccine
Liquid Biopsy
Early Cancer Detection
mHealth
Digital Pathology
In Vitro Diagnostics